Healthcare provider profile · identity verified

Samandip Singh Hothi, MD

Internal Medicine · FEDERAL WAY, WA · NPI 1992185136

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	443	138
Amlodipine Besylate	Amlodipine Besylate	314	106
Gabapentin	Gabapentin	280	86
Levothyroxine Sodium	Levothyroxine Sodium	214	52
Omeprazole	Omeprazole	198	58
Trazodone Hcl	Trazodone Hcl	193	59
Losartan Potassium	Losartan Potassium	191	64
Tamsulosin Hcl	Tamsulosin Hcl	180	64
Rosuvastatin Calcium	Rosuvastatin Calcium	154	51
Lisinopril	Lisinopril	147	51
Furosemide	Furosemide	141	43
Metoprolol Succinate	Metoprolol Succinate	132	54
Carvedilol	Carvedilol	127	40
Famotidine	Famotidine	107	43
Pantoprazole Sodium	Pantoprazole Sodium	105	37
Hydrochlorothiazide	Hydrochlorothiazide	97	33
Sertraline Hcl	Sertraline Hcl	94	32
Albuterol Sulfate Hfa	Albuterol Sulfate	93	39
Fluticasone Propionate	Fluticasone Propionate	93	34
Duloxetine Hcl	Duloxetine Hcl	87	28
Ozempic	Semaglutide	79	19
Metformin Hcl Er	Metformin Hcl	77	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	77	17
Eliquis	Apixaban	74	18
Glipizide Er	Glipizide	72	20
Diclofenac Sodium	Diclofenac Sodium	71	24
Metformin Hcl	Metformin Hcl	71	27
Potassium Chloride	Potassium Chloride	71	21
Allopurinol	Allopurinol	70	22
Oxycodone Hcl	Oxycodone Hcl	62	13
Xarelto	Rivaroxaban	62	16
Torsemide	Torsemide	61	12
Olmesartan Medoxomil	Olmesartan Medoxomil	59	27
Mirtazapine	Mirtazapine	58	16
Fluoxetine Hcl	Fluoxetine Hcl	57	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	27
Jardiance	Empagliflozin	55	23
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	51	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	18
Meloxicam	Meloxicam	48	17
Methocarbamol	Methocarbamol	47	23
Azithromycin	Azithromycin	44	26
Clopidogrel	Clopidogrel Bisulfate	43	14
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Simvastatin	Simvastatin	43	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	17
Metoprolol Tartrate	Metoprolol Tartrate	42	suppressed
Prednisone	Prednisone	42	26
Spironolactone	Spironolactone	42	11
Alendronate Sodium	Alendronate Sodium	41	13
Oxybutynin Chloride Er	Oxybutynin Chloride	41	17
Triamcinolone Acetonide	Triamcinolone Acetonide	40	19
Aripiprazole	Aripiprazole	39	18
Mupirocin	Mupirocin	39	15
Montelukast Sodium	Montelukast Sodium	38	15
Clonazepam	Clonazepam	37	suppressed
Glimepiride	Glimepiride	37	11
Amitriptyline Hcl	Amitriptyline Hcl	36	13
Ibandronate Sodium	Ibandronate Sodium	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	13
Lorazepam	Lorazepam	33	14
Pregabalin	Pregabalin	33	13
Tizanidine Hcl	Tizanidine Hcl	33	11
Baclofen	Baclofen	32	12
Mounjaro	Tirzepatide	31	suppressed
Propranolol Hcl Er	Propranolol Hcl	31	11
Alprazolam	Alprazolam	29	suppressed
Lidocaine	Lidocaine	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	11
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Hydrocortisone	Hydrocortisone	27	13
Propranolol Hcl	Propranolol Hcl	27	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Azelastine Hcl	Azelastine Hcl	24	12
Finasteride	Finasteride	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Cephalexin	Cephalexin	22	20
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Ciclopirox	Ciclopirox	21	suppressed
Colchicine	Colchicine	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Topiramate	Topiramate	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Lactulose	Lactulose	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Naproxen	Naproxen	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Rybelsus	Semaglutide	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Glipizide	Glipizide	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Atenolol	Atenolol	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Lithium Carbonate Er	Lithium Carbonate	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error